StonvexLoading…
StonvexStonvexStonvexCore line items from MUSA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $19.38B | $20.24B | $21.53B | $23.45B |
Operating Income | $718.50M | $742.90M | $826.00M | $968.40M |
Net Income | $470.60M | $502.50M | $556.80M | $672.90M |
EPS (Diluted) | $24.10 | $24.11 | $25.49 | $28.10 |
Total Assets | $4.73B | $4.54B | $4.34B | $4.12B |
Total Liabilities | $4.10B | $3.70B | $3.51B | $3.48B |
Cash & Equivalents | $28.90M | $47.00M | $117.80M | $60.50M |
Free Cash Flow OCF − CapEx | $374.30M | $389.50M | $448.40M | $689.40M |
Shares Outstanding | 19.53M | 20.84M | 21.84M | 23.95M |